Compendium of Cancer Genome Aberrations

DIG5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 16: Line 16:
!'''Date of Last Editor Review'''
!'''Date of Last Editor Review'''
!'''Notes'''
!'''Notes'''
|-
|CHAPTER 2 (TUMOURS OF THE OESOPHAGUS)
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|-
|[[DIG5:Oesophageal_squamous_papilloma|Oesophageal squamous papilloma]]
|[[DIG5:Oesophageal_squamous_papilloma|Oesophageal squamous papilloma]]
Line 115: Line 135:
|
|
|
|
|-
|CHAPTER 3 (TUMOURS OF THE STOMACH)
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|-
|[[DIG5:Fundic_gland_polyps_|Fundic gland polyps]]
|[[DIG5:Fundic_gland_polyps_|Fundic gland polyps]]
Line 259: Line 299:
|
|
|-
|-
|[[DIG5:Non-ampullary_adenoma|Non-ampullary adenoma]]
|CHAPTER 4 (TUMOURS OF THE SMALL INTESTINE AND AMPULLA)
|Disease
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|-
|-
|[[DIG5:Ampullary_adenoma|Ampullary adenoma]]
|[[DIG5:Non-ampullary_adenoma|Non-ampullary adenoma]]
|Disease
|Disease
|
|
Line 281: Line 330:
|
|
|-
|-
|[[DIG5:Non-ampullary_adenocarcinoma_|Non-ampullary adenocarcinoma]]
|[[DIG5:Ampullary_adenoma|Ampullary adenoma]]
|Disease
|Disease
|
|
Line 292: Line 341:
|
|
|-
|-
|[[DIG5:Ampullary_adenocarcinoma_|Ampullary adenocarcinoma]]
|[[DIG5:Non-ampullary_adenocarcinoma_|Non-ampullary adenocarcinoma]]
|Disease
|Disease
|
|
Line 303: Line 352:
|
|
|-
|-
|[[DIG5:Small_intestinal_and_ampullary_neuroendocrine_neoplasms_|Small intestinal and ampullary neuroendocrine neoplasms]]
|[[DIG5:Ampullary_adenocarcinoma_|Ampullary adenocarcinoma]]
|Disease
|Disease
|
|
Line 314: Line 363:
|
|
|-
|-
|[[DIG5:Appendiceal_serrated_lesions_and_polyps|Appendiceal serrated lesions and polyps]]
|[[DIG5:Small_intestinal_and_ampullary_neuroendocrine_neoplasms_|Small intestinal and ampullary neuroendocrine neoplasms]]
|Disease
|Disease
|
|
Line 325: Line 374:
|
|
|-
|-
|[[DIG5:Appendiceal_mucinous_neoplasm_|Appendiceal mucinous neoplasm]]
|CHAPTER 5 (TUMOURS OF THE APPENDIX)
|Disease
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|-
|-
|[[DIG5:Appendiceal_adenocarcinoma|Appendiceal adenocarcinoma]]
|[[DIG5:Appendiceal_serrated_lesions_and_polyps|Appendiceal serrated lesions and polyps]]
|Disease
|Disease
|
|
Line 347: Line 405:
|
|
|-
|-
|[[DIG5:Appendiceal_goblet_cell_adenocarcinoma|Appendiceal goblet cell adenocarcinoma]]
|[[DIG5:Appendiceal_mucinous_neoplasm_|Appendiceal mucinous neoplasm]]
|Disease
|Disease
|
|
Line 358: Line 416:
|
|
|-
|-
|[[DIG5:Appendiceal_neuroendocrine_neoplasms_|Appendiceal neuroendocrine neoplasms]]
|[[DIG5:Appendiceal_adenocarcinoma|Appendiceal adenocarcinoma]]
|Disease
|Disease
|
|
Line 369: Line 427:
|
|
|-
|-
|[[DIG5:Colorectal_serrated_lesions_and_polyps|Colorectal serrated lesions and polyps]]
|[[DIG5:Appendiceal_goblet_cell_adenocarcinoma|Appendiceal goblet cell adenocarcinoma]]
|Disease
|Disease
|
|
Line 380: Line 438:
|
|
|-
|-
|[[DIG5:Conventional_colorectal_adenoma_|Conventional colorectal adenoma]]
|[[DIG5:Appendiceal_neuroendocrine_neoplasms_|Appendiceal neuroendocrine neoplasms]]
|Disease
|Disease
|
|
Line 391: Line 449:
|
|
|-
|-
|[[DIG5:Inflammatory_bowel_disease-associated_dysplasia_of_the_colorectum|Inflammatory bowel disease-associated dysplasia of the colorectum]]
|CHAPTER 6 (TUMOURS OF THE COLON AND RECTUM)
|Disease
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|-
|-
|[[DIG5:Colorectal_adenocarcinoma_|Colorectal adenocarcinoma]]
|[[DIG5:Colorectal_serrated_lesions_and_polyps|Colorectal serrated lesions and polyps]]
|Disease
|Disease
|
|
Line 413: Line 480:
|
|
|-
|-
|[[DIG5:Colorectal_neuroendocrine_neoplasms_|Colorectal neuroendocrine neoplasms]]
|[[DIG5:Conventional_colorectal_adenoma_|Conventional colorectal adenoma]]
|Disease
|Disease
|
|
Line 424: Line 491:
|
|
|-
|-
|[[DIG5:Inflammatory_cloacogenic_polyp|Inflammatory cloacogenic polyp]]
|[[DIG5:Inflammatory_bowel_disease-associated_dysplasia_of_the_colorectum|Inflammatory bowel disease-associated dysplasia of the colorectum]]
|Disease
|Disease
|
|
Line 435: Line 502:
|
|
|-
|-
|[[DIG5:Anal_condyloma|Anal condyloma]]
|[[DIG5:Colorectal_adenocarcinoma_|Colorectal adenocarcinoma]]
|Disease
|Disease
|
|
Line 446: Line 513:
|
|
|-
|-
|[[DIG5:Anal_squamous_dysplasia_(intraepithelial_neoplasia)|Anal squamous dysplasia (intraepithelial neoplasia)]]
|[[DIG5:Colorectal_neuroendocrine_neoplasms_|Colorectal neuroendocrine neoplasms]]
|Disease
|Disease
|
|
Line 457: Line 524:
|
|
|-
|-
|[[DIG5:Anal_squamous_cell_carcinoma|Anal squamous cell carcinoma]]
|CHAPTER 7 (TUMOURS OF THE ANAL CANAL)
|Disease
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|-
|-
|[[DIG5:Anal_adenocarcinoma|Anal adenocarcinoma]]
|[[DIG5:Inflammatory_cloacogenic_polyp|Inflammatory cloacogenic polyp]]
|Disease
|Disease
|
|
Line 479: Line 555:
|
|
|-
|-
|[[DIG5:Anal_neuroendocrine_neoplasms|Anal neuroendocrine neoplasms]]
|[[DIG5:Anal_condyloma|Anal condyloma]]
|Disease
|Disease
|
|
Line 490: Line 566:
|
|
|-
|-
|[[DIG5:Focal_nodular_hyperplasia_of_the_liver|Focal nodular hyperplasia of the liver]]
|[[DIG5:Anal_squamous_dysplasia_(intraepithelial_neoplasia)|Anal squamous dysplasia (intraepithelial neoplasia)]]
|Disease
|Disease
|
|
Line 501: Line 577:
|
|
|-
|-
|[[DIG5:Hepatocellular_adenoma_|Hepatocellular adenoma]]
|[[DIG5:Anal_squamous_cell_carcinoma|Anal squamous cell carcinoma]]
|Disease
|Disease
|
|
Line 512: Line 588:
|
|
|-
|-
|[[DIG5:Hepatocellular_carcinoma|Hepatocellular carcinoma]]
|[[DIG5:Anal_adenocarcinoma|Anal adenocarcinoma]]
|Disease
|Disease
|
|
Line 523: Line 599:
|
|
|-
|-
|[[DIG5:Hepatoblastoma|Hepatoblastoma]]
|[[DIG5:Anal_neuroendocrine_neoplasms|Anal neuroendocrine neoplasms]]
|Disease
|Disease
|
|
Line 534: Line 610:
|
|
|-
|-
|[[DIG5:Bile_duct_adenoma|Bile duct adenoma]]
|CHAPTER 8 (TUMOURS OF THE LIVER AND INTRAHEPATIC BILE DUCTS)
|Disease
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|-
|-
|[[DIG5:Biliary_adenofibroma|Biliary adenofibroma]]
|[[DIG5:Focal_nodular_hyperplasia_of_the_liver|Focal nodular hyperplasia of the liver]]
|Disease
|Disease
|
|
Line 556: Line 641:
|
|
|-
|-
|[[DIG5:Mucinous_cystic_neoplasm_of_the_liver_and_biliary_system|Mucinous cystic neoplasm of the liver and biliary system]]
|[[DIG5:Hepatocellular_adenoma_|Hepatocellular adenoma]]
|Disease
|Disease
|
|
Line 567: Line 652:
|
|
|-
|-
|[[DIG5:Intrahepatic_cholangiocarcinoma|Intrahepatic cholangiocarcinoma]]
|[[DIG5:Hepatocellular_carcinoma|Hepatocellular carcinoma]]
|Disease
|Disease
|
|
Line 578: Line 663:
|
|
|-
|-
|[[DIG5:Combined_hepatocellular-cholangiocarcinoma_and_undifferentiated_primary_liver_carcinoma|Combined hepatocellular-cholangiocarcinoma and undifferentiated primary liver carcinoma]]
|[[DIG5:Hepatoblastoma|Hepatoblastoma]]
|Disease
|Disease
|
|
Line 589: Line 674:
|
|
|-
|-
|[[DIG5:Hepatic_neuroendocrine_neoplasms_|Hepatic neuroendocrine neoplasms]]
|[[DIG5:Bile_duct_adenoma|Bile duct adenoma]]
|Disease
|Disease
|
|
Line 600: Line 685:
|
|
|-
|-
|[[DIG5:Pyloric_gland_adenoma_of_the_gallbladder|Pyloric gland adenoma of the gallbladder]]
|[[DIG5:Biliary_adenofibroma|Biliary adenofibroma]]
|Disease
|Disease
|
|
Line 611: Line 696:
|
|
|-
|-
|[[DIG5:Biliary_intraepithelial_neoplasia_|Biliary intraepithelial neoplasia]]
|[[DIG5:Mucinous_cystic_neoplasm_of_the_liver_and_biliary_system|Mucinous cystic neoplasm of the liver and biliary system]]
|Disease
|Disease
|
|
Line 622: Line 707:
|
|
|-
|-
|[[DIG5:Intracholecystic_papillary_neoplasm_(formerly_Intracystic_/_intraductal_papillary_neoplasm)_|Intracholecystic papillary neoplasm (formerly Intracystic / intraductal papillary neoplasm)]]
|[[DIG5:Intrahepatic_cholangiocarcinoma|Intrahepatic cholangiocarcinoma]]
|Disease
|Disease
|
|
Line 633: Line 718:
|
|
|-
|-
|[[DIG5:Intraductal_papillary_neoplasm_of_the_bile_ducts|Intraductal papillary neoplasm of the bile ducts]]
|[[DIG5:Combined_hepatocellular-cholangiocarcinoma_and_undifferentiated_primary_liver_carcinoma|Combined hepatocellular-cholangiocarcinoma and undifferentiated primary liver carcinoma]]
|Disease
|Disease
|
|
Line 644: Line 729:
|
|
|-
|-
|[[DIG5:Carcinoma_of_the_gallbladder|Carcinoma of the gallbladder]]
|[[DIG5:Hepatic_neuroendocrine_neoplasms_|Hepatic neuroendocrine neoplasms]]
|Disease
|Disease
|
|
Line 655: Line 740:
|
|
|-
|-
|[[DIG5:Carcinoma_of_the_extrahepatic_bile_ducts|Carcinoma of the extrahepatic bile ducts]]
|CHAPTER 9 (TUMOURS OF THE GALLBLADDER AND EXTRAHEPATIC BILE DUCTS)
|Disease
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|-
|-
|[[DIG5:Neuroendocrine_neoplasms_of_the_gallbladder_and_bile_ducts|Neuroendocrine neoplasms of the gallbladder and bile ducts]]
|[[DIG5:Pyloric_gland_adenoma_of_the_gallbladder|Pyloric gland adenoma of the gallbladder]]
|Disease
|Disease
|
|
Line 677: Line 771:
|
|
|-
|-
|[[DIG5:Acinar_cystic_transformation_of_the_pancreas|Acinar cystic transformation of the pancreas]]
|[[DIG5:Biliary_intraepithelial_neoplasia_|Biliary intraepithelial neoplasia]]
|Disease
|Disease
|
|
Line 688: Line 782:
|
|
|-
|-
|[[DIG5:Serous_neoplasms_of_the_pancreas|Serous neoplasms of the pancreas]]
|[[DIG5:Intracholecystic_papillary_neoplasm_(formerly_Intracystic_/_intraductal_papillary_neoplasm)_|Intracholecystic papillary neoplasm (formerly Intracystic / intraductal papillary neoplasm)]]
|Disease
|Disease
|
|
Line 699: Line 793:
|
|
|-
|-
|[[DIG5:Pancreatic_intraepithelial_neoplasia_|Pancreatic intraepithelial neoplasia]]
|[[DIG5:Intraductal_papillary_neoplasm_of_the_bile_ducts|Intraductal papillary neoplasm of the bile ducts]]
|Disease
|Disease
|
|
Line 710: Line 804:
|
|
|-
|-
|[[DIG5:Pancreatic_intraductal_papillary_mucinous_neoplasm_|Pancreatic intraductal papillary mucinous neoplasm]]
|[[DIG5:Carcinoma_of_the_gallbladder|Carcinoma of the gallbladder]]
|Disease
|Disease
|
|
Line 721: Line 815:
|
|
|-
|-
|[[DIG5:Pancreatic_intraductal_oncocytic_papillary_neoplasm_|Pancreatic intraductal oncocytic papillary neoplasm]]
|[[DIG5:Carcinoma_of_the_extrahepatic_bile_ducts|Carcinoma of the extrahepatic bile ducts]]
|Disease
|Disease
|
|
Line 732: Line 826:
|
|
|-
|-
|[[DIG5:Pancreatic_intraductal_tubulopapillary_neoplasm_|Pancreatic intraductal tubulopapillary neoplasm]]
|[[DIG5:Neuroendocrine_neoplasms_of_the_gallbladder_and_bile_ducts|Neuroendocrine neoplasms of the gallbladder and bile ducts]]
|Disease
|Disease
|
|
Line 743: Line 837:
|
|
|-
|-
|[[DIG5:Pancreatic_mucinous_cystic_neoplasm_|Pancreatic mucinous cystic neoplasm]]
|CHAPTER 10 (TUMOURS OF THE PANCREAS)
|Disease
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|-
|-
|[[DIG5:Pancreatic_ductal_adenocarcinoma|Pancreatic ductal adenocarcinoma]]
|[[DIG5:Acinar_cystic_transformation_of_the_pancreas|Acinar cystic transformation of the pancreas]]
|Disease
|Disease
|
|
Line 765: Line 868:
|
|
|-
|-
|[[DIG5:Pancreatic_acinar_cell_carcinoma|Pancreatic acinar cell carcinoma]]
|[[DIG5:Serous_neoplasms_of_the_pancreas|Serous neoplasms of the pancreas]]
|Disease
|Disease
|
|
Line 776: Line 879:
|
|
|-
|-
|[[DIG5:Pancreatoblastoma|Pancreatoblastoma]]
|[[DIG5:Pancreatic_intraepithelial_neoplasia_|Pancreatic intraepithelial neoplasia]]
|Disease
|Disease
|
|
Line 787: Line 890:
|
|
|-
|-
|[[DIG5:Solid_pseudopapillary_neoplasm_of_the_pancreas|Solid pseudopapillary neoplasm of the pancreas]]
|[[DIG5:Pancreatic_intraductal_papillary_mucinous_neoplasm_|Pancreatic intraductal papillary mucinous neoplasm]]
|Disease
|Disease
|
|
Line 798: Line 901:
|
|
|-
|-
|[[DIG5:Non-functioning_pancreatic_neuroendocrine_tumours|Non-functioning pancreatic neuroendocrine tumours]]
|[[DIG5:Pancreatic_intraductal_oncocytic_papillary_neoplasm_|Pancreatic intraductal oncocytic papillary neoplasm]]
|Disease
|Disease
|
|
Line 809: Line 912:
|
|
|-
|-
|[[DIG5:Insulinoma|Insulinoma]]
|[[DIG5:Pancreatic_intraductal_tubulopapillary_neoplasm_|Pancreatic intraductal tubulopapillary neoplasm]]
|Disease
|Disease
|
|
Line 820: Line 923:
|
|
|-
|-
|[[DIG5:Gastrinoma|Gastrinoma]]
|[[DIG5:Pancreatic_mucinous_cystic_neoplasm_|Pancreatic mucinous cystic neoplasm]]
|Disease
|Disease
|
|
Line 831: Line 934:
|
|
|-
|-
|[[DIG5:VIPoma|VIPoma]]
|[[DIG5:Pancreatic_ductal_adenocarcinoma|Pancreatic ductal adenocarcinoma]]
|Disease
|Disease
|
|
Line 842: Line 945:
|
|
|-
|-
|[[DIG5:Glucagonoma|Glucagonoma]]
|[[DIG5:Pancreatic_acinar_cell_carcinoma|Pancreatic acinar cell carcinoma]]
|Disease
|Disease
|
|
Line 853: Line 956:
|
|
|-
|-
|[[DIG5:Somatostatinoma|Somatostatinoma]]
|[[DIG5:Pancreatoblastoma|Pancreatoblastoma]]
|Disease
|Disease
|
|
Line 864: Line 967:
|
|
|-
|-
|[[DIG5:ACTH-producing_neuroendocrine_tumour|ACTH-producing neuroendocrine tumour]]
|[[DIG5:Solid_pseudopapillary_neoplasm_of_the_pancreas|Solid pseudopapillary neoplasm of the pancreas]]
|Disease
|Disease
|
|
Line 875: Line 978:
|
|
|-
|-
|[[DIG5:Serotonin-producing_neuroendocrine_tumour|Serotonin-producing neuroendocrine tumour]]
|[[DIG5:Non-functioning_pancreatic_neuroendocrine_tumours|Non-functioning pancreatic neuroendocrine tumours]]
|Disease
|Disease
|
|
Line 886: Line 989:
|
|
|-
|-
|[[DIG5:Pancreatic_neuroendocrine_carcinoma|Pancreatic neuroendocrine carcinoma]]
|[[DIG5:Insulinoma|Insulinoma]]
|Disease
|Disease
|
|
Line 897: Line 1,000:
|
|
|-
|-
|[[DIG5:Pancreatic_MiNENs|Pancreatic MiNENs]]
|[[DIG5:Gastrinoma|Gastrinoma]]
|Disease
|Disease
|
|
Line 908: Line 1,011:
|
|
|-
|-
|[[DIG5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)_involving_the_digestive_tract|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) involving the digestive tract]]
|[[DIG5:VIPoma|VIPoma]]
|Disease
|Disease
|
|
Line 919: Line 1,022:
|
|
|-
|-
|[[DIG5:Duodenal-type_follicular_lymphoma|Duodenal-type follicular lymphoma]]
|[[DIG5:Glucagonoma|Glucagonoma]]
|Disease
|Disease
|
|
Line 930: Line 1,033:
|
|
|-
|-
|[[DIG5:Enteropathy-associated_T-cell_lymphoma_|Enteropathy-associated T-cell lymphoma]]
|[[DIG5:Somatostatinoma|Somatostatinoma]]
|Disease
|Disease
|
|
Line 941: Line 1,044:
|
|
|-
|-
|[[DIG5:Monomorphic_epitheliotropic_intestinal_T-cell_lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]
|[[DIG5:ACTH-producing_neuroendocrine_tumour|ACTH-producing neuroendocrine tumour]]
|Disease
|Disease
|
|
Line 952: Line 1,055:
|
|
|-
|-
|[[DIG5:Intestinal_T-cell_lymphoma_NOS|Intestinal T-cell lymphoma NOS]]
|[[DIG5:Serotonin-producing_neuroendocrine_tumour|Serotonin-producing neuroendocrine tumour]]
|Disease
|Disease
|
|
Line 963: Line 1,066:
|
|
|-
|-
|[[DIG5:Indolent_T-cell_lymphoproliferative_disorder_of_the_GI_tract|Indolent T-cell lymphoproliferative disorder of the GI tract]]
|[[DIG5:Pancreatic_neuroendocrine_carcinoma|Pancreatic neuroendocrine carcinoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Pancreatic_MiNENs|Pancreatic MiNENs]]
|Disease
|
|
|
|
|
|
|
|
|-
|CHAPTER 11 (HAEMATOLYMPHOID TUMOURS OF THE DIGESTIVE SYSTEM)
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|[[DIG5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)_involving_the_digestive_tract|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) involving the digestive tract]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Duodenal-type_follicular_lymphoma|Duodenal-type follicular lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Enteropathy-associated_T-cell_lymphoma_|Enteropathy-associated T-cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Monomorphic_epitheliotropic_intestinal_T-cell_lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Intestinal_T-cell_lymphoma_NOS|Intestinal T-cell lymphoma NOS]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Indolent_T-cell_lymphoproliferative_disorder_of_the_GI_tract|Indolent T-cell lymphoproliferative disorder of the GI tract]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Hepatosplenic_T-cell_lymphoma|Hepatosplenic T-cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:EBV+_inflammatory_follicular_dendritic_cell_sarcoma_of_the_digestive_tract|EBV+ inflammatory follicular dendritic cell sarcoma of the digestive tract]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Follicular_lymphoma|Follicular lymphoma]]
|Disease
|
|
|
|
Line 974: Line 1,218:
|
|
|-
|-
|[[DIG5:Hepatosplenic_T-cell_lymphoma|Hepatosplenic T-cell lymphoma]]
|[[DIG5:Mantle_cell_lymphoma_|Mantle cell lymphoma]]
|Disease
|Disease
|
|
Line 985: Line 1,229:
|
|
|-
|-
|[[DIG5:EBV+_inflammatory_follicular_dendritic_cell_sarcoma_of_the_digestive_tract|EBV+ inflammatory follicular dendritic cell sarcoma of the digestive tract]]
|[[DIG5:Burkitt_lymphoma|Burkitt lymphoma]]
|Disease
|Disease
|
|
Line 996: Line 1,240:
|
|
|-
|-
|[[DIG5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
|[[DIG5:Plasmablastic_lymphoma|Plasmablastic lymphoma]]
|Disease
|Disease
|
|
Line 1,007: Line 1,251:
|
|
|-
|-
|[[DIG5:Follicular_lymphoma|Follicular lymphoma]]
|[[DIG5:Posttransplant_lymphoproliferative_disorders|Posttransplant lymphoproliferative disorders]]
|Disease
|Disease
|
|
Line 1,018: Line 1,262:
|
|
|-
|-
|[[DIG5:Mantle_cell_lymphoma_|Mantle cell lymphoma]]
|[[DIG5:Extranodal_NK/T-cell_lymphoma_|Extranodal NK/T-cell lymphoma]]
|Disease
|Disease
|
|
Line 1,029: Line 1,273:
|
|
|-
|-
|[[DIG5:Burkitt_lymphoma|Burkitt lymphoma]]
|[[DIG5:Systemic_mastocytosis|Systemic mastocytosis]]
|Disease
|Disease
|
|
Line 1,040: Line 1,284:
|
|
|-
|-
|[[DIG5:Plasmablastic_lymphoma|Plasmablastic lymphoma]]
|[[DIG5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
|Disease
|Disease
|
|
Line 1,051: Line 1,295:
|
|
|-
|-
|[[DIG5:Posttransplant_lymphoproliferative_disorders|Posttransplant lymphoproliferative disorders]]
|[[DIG5:Follicular_dendritic_cell_sarcoma|Follicular dendritic cell sarcoma]]
|Disease
|Disease
|
|
Line 1,062: Line 1,306:
|
|
|-
|-
|[[DIG5:Extranodal_NK/T-cell_lymphoma_|Extranodal NK/T-cell lymphoma]]
|[[DIG5:Histiocytic_sarcoma|Histiocytic sarcoma]]
|Disease
|Disease
|
|
Line 1,073: Line 1,317:
|
|
|-
|-
|[[DIG5:Systemic_mastocytosis|Systemic mastocytosis]]
|CHAPTER 12 (MESENCHYMAL TUMOURS OF THE DIGESTIVE SYSTEM)
|Disease
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|-
|-
|[[DIG5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
|[[DIG5:Gastrointestinal_stromal_tumour_|Gastrointestinal stromal tumour]]
|Disease
|Disease
|
|
Line 1,095: Line 1,348:
|
|
|-
|-
|[[DIG5:Follicular_dendritic_cell_sarcoma|Follicular dendritic cell sarcoma]]
|[[DIG5:Inflammatory_myofibroblastic_tumour_|Inflammatory myofibroblastic tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Histiocytic_sarcoma|Histiocytic sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Gastrointestinal_stromal_tumour_|Gastrointestinal stromal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Inflammatory_myofibroblastic_tumour_|Inflammatory myofibroblastic tumour]]
|Disease
|Disease
|
|
Line 1,402: Line 1,622:
|
|
|
|
|-
|CHAPTER 13 (OTHER TUMOURS OF THE DIGESTIVE SYSTEM)
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|-
|[[DIG5:Mucosal_melanoma_of_the_digestive_system|Mucosal melanoma of the digestive system]]
|[[DIG5:Mucosal_melanoma_of_the_digestive_system|Mucosal melanoma of the digestive system]]
Retrieved from "https://test.ccga.io/index.php/DIG5:Volunteer_Assignments_and_Opportunities"